# A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer

> **NCT06155422** · — · NOT_YET_RECRUITING · sponsor: **Gang Chen (101199)** · enrollment: 670 (estimated)

## Conditions studied

- Recurrent or Metastatic Cervical Cancer

## Interventions

- **DRUG:** Cadonilimab

## Key facts

- **NCT ID:** NCT06155422
- **Lead sponsor:** Gang Chen (101199)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-11-30
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 670 (ESTIMATED)
- **Last updated:** 2023-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06155422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06155422, "A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06155422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*